BE836563A - 2-decarboxy - 2 - (tetrazol - 5 - yl) - 11 - desocy - omega - pentanor - prostaglandines subsituees en position 15 - Google Patents

2-decarboxy - 2 - (tetrazol - 5 - yl) - 11 - desocy - omega - pentanor - prostaglandines subsituees en position 15

Info

Publication number: BE836563A
Authority: BE; Belgium
Prior art keywords: desocy; pentanor; decarboxy; subsidized; tetrazol
Prior art date: 1974-12-11

Application number

BE1007075A

Other languages

English (en)

French (fr)

Inventor

M R Johnson

T K Schaaf

J F Eggler

J S Bindra

H-J E Hess

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1974-12-11

Filing date

1975-12-11

Publication date

1976-06-11

1975-12-11 Application filed filed Critical

1976-06-11 Publication of BE836563A publication Critical patent/BE836563A/xx

Links

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D257/00—Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms
- C07D257/02—Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms not condensed with other rings
- C07D257/04—Five-membered rings
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/38—Heterocyclic compounds having sulfur as a ring hetero atom
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C405/00—Compounds containing a five-membered ring having two side-chains in ortho position to each other, and having oxygen atoms directly attached to the ring in ortho position to one of the side-chains, one side-chain containing, not directly attached to the ring, a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, and the other side-chain having oxygen atoms attached in gamma-position to the ring, e.g. prostaglandins ; Analogues or derivatives thereof
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C61/00—Compounds having carboxyl groups bound to carbon atoms of rings other than six-membered aromatic rings
- C07C61/06—Saturated compounds having a carboxyl group bound to a five-membered ring
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C69/00—Esters of carboxylic acids; Esters of carbonic or haloformic acids
- C07C69/74—Esters of carboxylic acids having an esterified carboxyl group bound to a carbon atom of a ring other than a six-membered aromatic ring
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D307/93—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems condensed with a ring other than six-membered
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D307/93—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems condensed with a ring other than six-membered
- C07D307/935—Not further condensed cyclopenta [b] furans or hydrogenated cyclopenta [b] furans
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D309/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
- C07D309/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
- C07D309/08—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D309/10—Oxygen atoms
- C07D309/12—Oxygen atoms only hydrogen atoms and one oxygen atom directly attached to ring carbon atoms, e.g. tetrahydropyranyl ethers
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D317/00—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
- C07D317/08—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
- C07D317/44—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D317/46—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems condensed with one six-membered ring
- C07D317/48—Methylenedioxybenzenes or hydrogenated methylenedioxybenzenes, unsubstituted on the hetero ring
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
- C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
- C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
- C07D333/06—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to the ring carbon atoms
- C07D333/24—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D407/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00
- C07D407/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings
- C07D407/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F7/00—Compounds containing elements of Groups 4 or 14 of the Periodic Table
- C07F7/02—Silicon compounds
- C07F7/08—Compounds having one or more C—Si linkages
- C07F7/18—Compounds having one or more C—Si linkages as well as one or more C—O—Si linkages
- C07F7/1804—Compounds having Si-O-C linkages
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F7/00—Compounds containing elements of Groups 4 or 14 of the Periodic Table
- C07F7/02—Silicon compounds
- C07F7/08—Compounds having one or more C—Si linkages
- C07F7/18—Compounds having one or more C—Si linkages as well as one or more C—O—Si linkages
- C07F7/1896—Compounds having one or more Si-O-acyl linkages
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/28—Phosphorus compounds with one or more P—C bonds
- C07F9/38—Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)]
- C07F9/40—Esters thereof
- C07F9/4003—Esters thereof the acid moiety containing a substituent or a structure which is considered as characteristic
- C07F9/4006—Esters of acyclic acids which can have further substituents on alkyl
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/28—Phosphorus compounds with one or more P—C bonds
- C07F9/38—Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)]
- C07F9/40—Esters thereof
- C07F9/4003—Esters thereof the acid moiety containing a substituent or a structure which is considered as characteristic
- C07F9/4056—Esters of arylalkanephosphonic acids
- C07F9/4059—Compounds containing the structure (RY)2P(=X)-(CH2)n-C(=O)-(CH2)m-Ar, (X, Y = O, S, Se; n>=1, m>=0)
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
- C07F9/6524—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having four or more nitrogen atoms as the only ring hetero atoms

Landscapes

Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Health & Medical Sciences (AREA)
General Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Medicinal Chemistry (AREA)
Public Health (AREA)
Pharmacology & Pharmacy (AREA)
Animal Behavior & Ethology (AREA)
Veterinary Medicine (AREA)
Epidemiology (AREA)
Molecular Biology (AREA)
Biochemistry (AREA)
Emergency Medicine (AREA)
Crystallography & Structural Chemistry (AREA)
Bioinformatics & Cheminformatics (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Engineering & Computer Science (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Plural Heterocyclic Compounds (AREA)

BE1007075A 1974-12-11 1975-12-11 2-decarboxy - 2 - (tetrazol - 5 - yl) - 11 - desocy - omega - pentanor - prostaglandines subsituees en position 15 BE836563A (fr)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
US05/531,675 US3932389A (en)	1974-12-11	1974-12-11	2-Descarboxy-2-(tetrazol-5-yl)-11-desoxy-15-substituted-.omega.-pentanorprostaglandins

Publications (1)

Publication Number	Publication Date
BE836563A true BE836563A (fr)	1976-06-11

Family

ID=24118587

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
BE1007075A BE836563A (fr)	1974-12-11	1975-12-11	2-decarboxy - 2 - (tetrazol - 5 - yl) - 11 - desocy - omega - pentanor - prostaglandines subsituees en position 15

Country Status (24)

Country	Link
US (1)	US3932389A (cs)
JP (2)	JPS5186465A (cs)
AR (1)	AR222623A1 (cs)
BE (1)	BE836563A (cs)
CA (1)	CA1059122A (cs)
CH (2)	CH614434A5 (cs)
CS (3)	CS191960B2 (cs)
DD (2)	DD129644A5 (cs)
DK (1)	DK560075A (cs)
ES (1)	ES443422A1 (cs)
FI (1)	FI62289C (cs)
FR (1)	FR2293927A1 (cs)
GB (2)	GB1515414A (cs)
GR (1)	GR58521B (cs)
HU (1)	HU175278B (cs)
IE (1)	IE42937B1 (cs)
IL (1)	IL48637A (cs)
LU (1)	LU73996A1 (cs)
NL (1)	NL163509C (cs)
NO (1)	NO145381C (cs)
NZ (1)	NZ179503A (cs)
SE (2)	SE415759B (cs)
YU (1)	YU313775A (cs)
ZA (1)	ZA757754B (cs)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4102894A (en) *	1975-11-19	1978-07-25	Pfizer Inc.	15-Substituted-ω-pentanorprostaglandins
US4035360A (en) *	1974-12-11	1977-07-12	Pfizer Inc.	Magnesium salts of 2-descarboxy-2-(tetrazol-5-yl)-11-desoxy-15-substituted-omega-pentanoprostaglandins
US3984400A (en) *	1975-10-21	1976-10-05	Pfizer Inc.	11-Desoxy-16-aryl-ω-tetranorprostaglandins
JPS5295670A (en) *	1976-02-04	1977-08-11	Pfizer	22decarboxyy225 tetrazoll55yl**11deoxyy omegaapentanolprostaglandine
US4342868A (en) *	1977-06-13	1982-08-03	Pfizer Inc.	2-Descarboxy-2-(tetrazol-5-yl)-16,16-dimethyl-17-(2-furyl)-ω-trisnorprostaglandin E2
US4404372A (en) *	1977-06-13	1983-09-13	Pfizer Inc.	15-Substituted-ω-pentanorprostaglandin derivatives
US4097601A (en) *	1977-08-26	1978-06-27	Pfizer Inc.	Bone deposition by 2-descarboxy-2-(tetrazol-5-yl)-11-dexosy-16-aryl prostaglandins
JPS54119464A (en) *	1979-02-02	1979-09-17	Pfizer	Intermediate for manufacturing 22decarboxyy 22tetrasoll55yl*111deoxyyomegaapentanol prostaglandin
JPS54119465A (en) *	1979-02-02	1979-09-17	Pfizer	Intermediate for manufacturing 22decarboxyy 22tetrasoll55yl*111deoxyyomegaapentanol prostaglandin
US4336372A (en) *	1979-04-02	1982-06-22	The Upjohn Company	2-Decarboxy-2-tetrazolyl-PG2 compounds
US4336393A (en) *	1979-04-02	1982-06-22	The Upjohn Company	2-Decarboxy-2-tetrazolyl-13,14-dihydro-PG1 compounds
US4336371A (en) *	1979-04-02	1982-06-22	The Upjohn Company	2-Decarboxy-2-tetrazolyl-13,14-dihydro-PG2 compounds
US4336392A (en) *	1979-04-02	1982-06-22	The Upjohn Company	2-Decarboxy-2-tetrazolyl-PG1 compounds
JPS5991116U (ja) *	1982-12-09	1984-06-20	名倉　啓介	バツクル
US5703108A (en) *	1996-02-28	1997-12-30	Pfizer Inc.	Bone deposition by certain prostaglandin agonists
HN1996000101A (es)	1996-02-28	1997-06-26	Inc Pfizer	Terapia combinada para la osteoporosis
US6531485B2 (en)	1997-06-23	2003-03-11	Pfizer Inc.	Prostaglandin agonists
US20010056060A1 (en) *	2000-02-07	2001-12-27	Cameron Kimberly O.	Treatment of osteoporsis with EP2/EP4 receptor selective agonists
US20020161026A1 (en) *	2000-11-07	2002-10-31	Paralkar Vishwas M.	Combination therapies for the stimulation of bone growth
WO2003018025A1 (en) *	2001-08-23	2003-03-06	Sucampo Ag	Method and composition for treatment of ocular hypertension and glaucoma
AU2003209571A1 (en) *	2002-03-18	2003-09-29	Pfizer Products Inc.	Use of selective ep4 receptor agonists for the treatment of liver failure, loss of patency of the ductus arteriosus, glaucoma or ocular hypertension
US20030220377A1 (en) *	2002-05-08	2003-11-27	Richard Chesworth	Indole compounds and their use as estrogen agonists/antagonists
US20040002524A1 (en) *	2002-06-24	2004-01-01	Richard Chesworth	Benzimidazole compounds and their use as estrogen agonists/antagonists
US20050203086A1 (en) *	2004-03-04	2005-09-15	Pfizer Inc.	Methods of treatment using an EP2 selective receptor agonist
US9284274B2 (en)	2005-12-07	2016-03-15	Ramot At Tel-Aviv University Ltd.	Chemical derivatives of jasmonate, pharmaceutical compositions and methods of use thereof
US20090291904A1 (en) *	2005-12-07	2009-11-26	Yoel Kashman	Chemical derivatives of jasmonate, pharmaceutical compositions and methods of use thereof
US9284252B2 (en)	2009-06-09	2016-03-15	Sepal Pharma Ltd.	Use of jasmonate ester derivatives for treating benign hyperproliferative skin disorders
US12589097B2 (en)	2018-02-21	2026-03-31	OrphAl Therapeutics Inc.	Apilimod compositions and methods of use
AU2019223014B2 (en)	2018-02-21	2024-10-17	Orphai Therapeutics Inc.	Combination therapy with apilimod and glutamatergic agents

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
BE788209A (fr) *	1971-09-01	1973-02-28	Pfizer	Derives tetrazoyliques des prostaglandines naturelles

1974
- 1974-12-11 US US05/531,675 patent/US3932389A/en not_active Expired - Lifetime
1975
- 1975-12-04 SE SE7513708A patent/SE415759B/xx unknown
- 1975-12-09 IL IL48637A patent/IL48637A/xx unknown
- 1975-12-09 GR GR49561A patent/GR58521B/el unknown
- 1975-12-09 NO NO754174A patent/NO145381C/no unknown
- 1975-12-09 IE IE2672/75A patent/IE42937B1/en unknown
- 1975-12-10 FI FI753474A patent/FI62289C/fi not_active IP Right Cessation
- 1975-12-10 CA CA241,440A patent/CA1059122A/en not_active Expired
- 1975-12-10 DK DK560075A patent/DK560075A/da not_active Application Discontinuation
- 1975-12-10 NZ NZ179503A patent/NZ179503A/xx unknown
- 1975-12-10 HU HU75PI500A patent/HU175278B/hu unknown
- 1975-12-11 LU LU73996A patent/LU73996A1/xx unknown
- 1975-12-11 ZA ZA757754A patent/ZA757754B/xx unknown
- 1975-12-11 GB GB50912/75A patent/GB1515414A/en not_active Expired
- 1975-12-11 NL NL7514447.A patent/NL163509C/xx not_active IP Right Cessation
- 1975-12-11 ES ES443422A patent/ES443422A1/es not_active Expired
- 1975-12-11 GB GB16030/77A patent/GB1515415A/en not_active Expired
- 1975-12-11 CH CH1319278A patent/CH614434A5/xx not_active IP Right Cessation
- 1975-12-11 FR FR7537943A patent/FR2293927A1/fr active Granted
- 1975-12-11 JP JP50148318A patent/JPS5186465A/ja active Granted
- 1975-12-11 CS CS758427A patent/CS191960B2/cs unknown
- 1975-12-11 BE BE1007075A patent/BE836563A/xx unknown
- 1975-12-11 CS CS77454A patent/CS191996B2/cs unknown
- 1975-12-11 AR AR261579A patent/AR222623A1/es active
- 1975-12-11 CH CH1610975A patent/CH612188A5/xx not_active IP Right Cessation
- 1975-12-11 CS CS77453A patent/CS191995B2/cs unknown
- 1975-12-11 YU YU03137/75A patent/YU313775A/xx unknown
1976
- 1976-01-07 DD DD7600197620A patent/DD129644A5/xx unknown
- 1976-01-07 DD DD7600197621A patent/DD129648A5/xx unknown
1977
- 1977-03-16 JP JP2912877A patent/JPS52116471A/ja active Granted
1979
- 1979-09-19 SE SE7907780A patent/SE7907780L/sv not_active Application Discontinuation

Also Published As

Publication number	Publication date
GB1515414A (en)	1978-06-21
JPS541711B2 (cs)	1979-01-27
YU313775A (en)	1982-06-30
GR58521B (en)	1977-10-29
FI62289C (fi)	1982-12-10
NO145381B (no)	1981-11-30
GB1515415A (en)	1978-06-21
IE42937L (en)	1976-06-11
DK560075A (da)	1976-06-12
CS191996B2 (en)	1979-07-31
JPS52116471A (en)	1977-09-29
IE42937B1 (en)	1980-11-19
CH614434A5 (cs)	1979-11-30
NL163509B (nl)	1980-04-15
JPS5186465A (en)	1976-07-29
NO754174L (cs)	1976-06-14
DD129648A5 (de)	1978-02-01
SE7907780L (sv)	1979-09-19
AU8736375A (en)	1977-06-02
CA1059122A (en)	1979-07-24
FR2293927B1 (cs)	1979-02-23
FI62289B (fi)	1982-08-31
IL48637A (en)	1979-12-30
ZA757754B (en)	1976-11-24
HU175278B (hu)	1980-06-28
LU73996A1 (cs)	1976-11-11
SE7513708L (sv)	1976-06-14
NZ179503A (en)	1978-07-10
AR222623A1 (es)	1981-06-15
FR2293927A1 (fr)	1976-07-09
ES443422A1 (es)	1977-04-16
FI753474A7 (cs)	1976-06-12
CS191960B2 (en)	1979-07-31
US3932389A (en)	1976-01-13
NL7514447A (nl)	1976-06-15
CH612188A5 (cs)	1979-07-13
IL48637A0 (en)	1976-02-29
JPS568035B2 (cs)	1981-02-20
NO145381C (no)	1982-03-10
CS191995B2 (en)	1979-07-31
NL163509C (nl)	1980-09-15
DD129644A5 (de)	1978-02-01
SE415759B (sv)	1980-10-27

Publication	Publication Date	Title
BE825146A (fr)	1975-08-04	Complexes d'antitranspiration
AT341933B (de)	1978-03-10	Sackchen
IT1050688B (it)	1981-03-20	Collegamento ad innesto
JPS5149790A (ja)	1976-04-30	Aikotonarukeikogensuijumyoojusuru 2 shuruinokeikoseibiryushishuzokuoshikibetsusuruhoho oyobisochi
JPS5143702A (ja)	1976-04-14	Zeoraitokyuchakuzainosentakutekikyuchakunyoru 1 33 butajennobunriho
HU172890B (hu)	1978-12-28	Dozimetr dlja registracii velichny zvuka ili shuma vyshe dannogo urovnja
IT1059524B (it)	1982-06-21	Proiettile in particolare proiettile anticarro
SE7507268L (sv)	1976-04-20	Suganordning
BE836564A (fr)	1976-06-11	11-desoxy-omega - pentanorprostaglandines substituees en position 15
JPS5119208A (ja)	1976-02-16	Kurankushitsuyoatsushukushiki 2 saikuruenjin
JPS5122606A (ja)	1976-02-23	Kanetsuroronaipaipuno 2 judannetsuhoho
TR18322A (tr)	1976-12-28	N-n-diallildikloroasetamid'in
BE832336A (fr)	1976-02-12	N-phosphonomethylglycine phenylhydrazides
FR2281036A7 (fr)	1976-02-27	Pompes
JPS5136506A (ja)	1976-03-27	Denkishimakisengajujoshitesochakusarenai 3 so no chokuryudendoki
SU504974A1 (ru)	1976-02-28	Датчик термоанемометра
JPS511422A (ja)	1976-01-08	Gensojonitsukerukarano 0 kanitsukerusakutaino seiho
SU499183A1 (ru)	1976-01-15	Мешок
SU490983A1 (ru)	1975-11-05	Многослоный клиновой ремень
IT1029956B (it)	1979-03-20	3 benzofurilcumarine
JPS5124109A (ja)	1976-02-26	Densobaitaiokaishitetanitsuno 4 sohenchohansohajode 2 tsunodokuritsunichojisareta 2 shinsudeetashingoososhinsuru tsushinsochi
IT1037961B (it)	1979-11-20	Compressore stradale
SE7405042L (sv)	1975-10-17	I ett stycke tillverkad pincett.
FR2279888A1 (fr)	1976-02-20	Balayeuse
IT1042758B (it)	1980-01-30	2 alogemohenzil eteri